Physician profile
Taijun Zhao
NPI 1033293410
$2,712.63
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,075 · 2020: $535 · 2021: $39.59 · 2022: $31.75 · 2024: $31.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $260.68 | 2019-2020 | |
| Allergan, INC. | $198.15 | 2019-2021 | |
| Biogen, INC. | $192.24 | 2019-2020 | |
| Amgen INC. | $175.77 | 2019-2022 | |
| Genzyme Corporation | $173.73 | 2019-2020 | |
| Grt US Holding, INC. | $169.16 | 2020-2022 | |
| Emd Serono, INC. | $161.66 | 2019-2020 | |
| Grifols USA, LLC | $149.92 | 2019 | |
| Alexion Pharmaceuticals, INC. | $144.51 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $140.84 | 2019-2020 | |
| Acorda Therapeutics, INC | $105.62 | 2019 | |
| Abbvie INC. | $84.07 | 2019-2024 | |
| Genentech USA, INC. | $82.49 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $79.90 | 2019 | |
| Ucb, INC. | $75.92 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $67.55 | 2019 | |
| Supernus Pharmaceuticals, INC. | $61.89 | 2019 | |
| Eisai INC. | $46.87 | 2019 | |
| Lilly USA, LLC | $42.83 | 2019-2020 | |
| Lundbeck LLC | $37.40 | 2019-2020 | |
| Ge Healthcare | $35.07 | 2019 | |
| Adamas Pharmaceuticals, INC. | $32.45 | 2019 | |
| Csl Behring | $31.52 | 2019 | |
| Livanova USA, INC. | $28.56 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $25.13 | 2019 | |
| Acadia Pharmaceuticals INC | $24.57 | 2020 | |
| Amneal Pharmaceuticals LLC | $23.15 | 2019-2020 | |
| Travere Therapeutics, INC. | $19.95 | 2019 | |
| Tanabe Pharma America, INC. | $15.69 | 2019 | |
| Upsher-Smith Laboratories LLC | $14.20 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taijun Zhao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.